These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 4105367)

  • 1. Decreased uroporphyrinogen decarboxylase activity in 'experimental symptomatic porphyria'.
    Taljaard JJ; Shanley BC; Joubert SM
    Life Sci II; 1971 Aug; 10(15):887-93. PubMed ID: 4105367
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation of uroporphyrinogen decarboxylase by ferrous iron in porphyria cutanea tarda.
    Blekkenhorst GH; Eales L; Pimstone NR
    S Afr Med J; 1979 Nov; 56(22):918-20. PubMed ID: 515872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual mechanism of inhibition of rat liver uroporphyrinogen decarboxylase activity by ferrous iron: its potential role in the genesis of porphyria cutanea tarda.
    Mukerji SK; Pimstone NR; Burns M
    Gastroenterology; 1984 Dec; 87(6):1248-54. PubMed ID: 6489695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative abilities on a molar basis of hexafluoro-, hexachloro- and hexabromobenzenes to decrease liver uroporphyrinogen decarboxylase activity and cause porphyria in female rats.
    Smith AG; Francis JE
    Res Commun Chem Pathol Pharmacol; 1980 May; 28(2):377-84. PubMed ID: 7394329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uroporphyrinogen decarboxylase deficiency in experimental chronic hepatic porphyria.
    von Tiepermann R; Koss G; Doss M
    Hoppe Seylers Z Physiol Chem; 1980 Aug; 361(8):1217-22. PubMed ID: 7409755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of polychlorinated biphenyl compounds, 2,3,7,8-tetrachlorodibenzo-p-dioxin, phenobarbital and iron on hepatic uroporphyrinogen decarboxylase. Implications for the pathogenesis of porphyria.
    De Verneuil H; Sassa S; Kappas A
    Biochem J; 1983 Jul; 214(1):145-51. PubMed ID: 6412692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental porphyria.
    Tschudy DP; Bonkowsky HL
    Fed Proc; 1972; 31(1):147-59. PubMed ID: 4109797
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunoreactive uroporphyrinogen decarboxylase is unchanged in porphyria caused by TCDD and hexachlorobenzene.
    Elder GH; Sheppard DM
    Biochem Biophys Res Commun; 1982 Nov; 109(1):113-20. PubMed ID: 7159416
    [No Abstract]   [Full Text] [Related]  

  • 9. [The enzymopathic nature of porphyria].
    Gajdos A
    Nouv Presse Med; 1976 May; 5(22):1417-22. PubMed ID: 778793
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hereditary and non-hereditary form of chronic hepatic porphyria: different behaviour of uroporphyrinogen decarboxylase in liver and erythrocytes (author's transl)].
    Doss M; von Tiepermann R; Look D; Henning H; Nikolowski J; Ryckmanns F; Braun-Falco O
    Klin Wochenschr; 1980 Dec; 58(24):1347-56. PubMed ID: 7206594
    [No Abstract]   [Full Text] [Related]  

  • 11. [Early forms of porphyria cutanea tarda. Apropos of 2 cases with a study of familial enzymatic deficiency and definition of the mode of genetic transmission].
    Herrero C; Muniesa AM; Lecha M; Elder GH; Mascaro JM
    Ann Dermatol Venereol; 1984; 111(11):973-8. PubMed ID: 6524816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The porphyria cutanea tarda group: their role among the enzyme defects of heme biosynthesis].
    Adrien A; Guillet G
    Sem Hop; 1984 Apr; 60(16):1148-52. PubMed ID: 6326308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental porphyria. I. The experimental porphyrias--a group of distinctive metabolic lesions.
    Sweeney GD; Janigan D; Mayman D; Lai H
    S Afr Med J; 1971 Sep; ():68-72. PubMed ID: 4113777
    [No Abstract]   [Full Text] [Related]  

  • 14. Abnormal kinetic behavior of uroporphyrinogen decarboxylase obtained from rats with hexachlorobenzene-induced porphyria.
    Chaufan G; Corvi MM; San Martín de Viale LC; Cárdenas ML; Ríos de Molina Mdel C
    J Biochem Mol Toxicol; 2005; 19(1):19-24. PubMed ID: 15736160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The determination of uroporphyrinogen decarboxylase in tissues by high-performance liquid chromatography coupled to fluorescence detection.
    Cantoni L; Ruggieri R; Dal Fiume D; Rizzardini M
    J Chromatogr; 1982 May; 229(2):311-8. PubMed ID: 7096469
    [No Abstract]   [Full Text] [Related]  

  • 16. The enzymatic defects in porphyria cutanea tarda and variegate porphyria.
    Kushner JP
    Acta Derm Venereol Suppl (Stockh); 1982; 100():51-6. PubMed ID: 6962633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uroporphyrinogen decarboxylase. A method for measuring enzyme activity.
    Straka JG; Kushner JP; Pryor MA
    Enzyme; 1982; 28(2-3):170-85. PubMed ID: 7140719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased red cell uroporphyrinogen I synthetase activity in intermittent acute porphyria.
    Strand LJ; Meyer UA; Felsher BF; Redeker AG; Marver HS
    J Clin Invest; 1972 Oct; 51(10):2530-6. PubMed ID: 5056653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alcohol-induced decrease in uroporphyrinogen decarboxylase activity in rat liver and spleen.
    Doss M; von Tiepermann R; Stutz G; Teschke R
    Enzyme; 1981; 26(1):24-31. PubMed ID: 7194180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental porphyria induced by chlorinated hydrocarbons. Studies of porphyrinogen carboxy-lyase in the experimental model of human cutaneous delayed porphyria].
    Ríos de Molina MC; Billi SC; Wainstok de Calmanovici R; San Martín de Viale LC
    Acta Physiol Pharmacol Latinoam; 1984; 34(4):393-407. PubMed ID: 6242264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.